Divergence between LDL oxidative susceptibility and urinary F2-isoprostanes as measures of oxidative stress in type 2 diabetes

Clinical Chemistry

Volumn 47, Issue 11, 2001, Pages 1974-1979

  Devaraj, S ^a   Hirany, S V ^a   Burk, R F ^a   Jialal, I ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; COPPER; CREATININE; ISOPROSTANE DERIVATIVE; LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GAS CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; OXIDATIVE STRESS;

EID: 0034781641     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.11.1974     Document Type: Article

References (33)

1. Oxidative stress as a regulator of gene expression in the vasculature
2. Oxidized phospholipids and isoprostanes in atherosclerosis
3. Low density lipoprotein oxidation, antioxidants and atherosclerosis: A clinical biochemistry perspective
4. Oxidized Iow density lipoprotein and atherosclerosis
5. The role of oxidized lipoproteins in atherogenesis
6. Atherogenesis in diabetes
7. Diabetes mellitus, vascular disease and thrombosis
8. Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation
9. Oxidative damage to DNA in diabetes mellitus
10. Autoantibodies against Ox-LDL in NIDDM
11. Vitamin E/Lipid peroxide ratio and susceptibility of LDL to oxidative modification in NIDDM
12. Enhanced susceptibility of LDL to in vitro oxidation in type 1 and 2 diabetic patients
13. Increased susceptibility of LDL to in vitro oxidation in patients with IDDM and NIDDM
14. Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes
15. 2-Isoprostanes: Sensitive and specific non-invasive indices of lipid peroxidation in vivo
16. The generation and actions of isoprostanes
17. Isoprostanes - Potential markers of oxidant stress in atherothrombotic disease
18. 2-α and platelet activation in diabetes mellitus-effect of improved metabolic control and vitamin E supplementation
19. 2 α levels are increased in individuals with NIDDM
20. LDL. Post-secretory modification, monocyte function and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: The effect of α tocopherol supplementation
21. The effect of a-tocopherol supplementation on LDL oxidation: A dose-response study
22. Assessment of lipoprotein peroxidation
23. Measurement of protein carbonyls by a sensitive ELISA
24. Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress
25. 2-isoprostanes in biological fluids and tissues as a measure of oxidant stress
26. Effects of vitamin e on lipid peroxidation in healthy persons
27. 2-isoprostanes as markers of in vivo lipid peroxidation-a comparison of EIA with GC/MS
28. Immunological characterization of urinary 8-epi PGF2 α excretion in man
29. Evolving lipoprotein risk factors: Lipoprotein 9a and oxidized LDL
30. Isoprostanes: Formation, analysis and use as indices of lipid peroxidation in vivo
31. Lipid peroxidation and atherosclerosis in type 2 diabetes
32. Effects of vitamin E on susceptibility of LDL and LDL subfractions to oxidation and on protein glycation in NIDDM
33. RRR-AT supplementation at pharmacological doses decreases LDL oxidative susceptibility but not protein glycation in patients with diabetes mellitus